Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate

As a bisphosphonate, minodronate (MIN) is one of the strongest inhibitors of bone resorption. However, there have been no reports directly comparing the antiresorptive effects of monthly MIN with those of monthly risedronate (RIS). We enrolled 30 cases of osteoporosis (OP; 16 in the MIN group [mean...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Osteoporos Sarcopenia
Main Authors: Kamimura, Mikio, Nakamura, Yukio, Ikegami, Shota, Komatsu, Masatoshi, Uchiyama, Shigeharu, Kato, Hiroyuki
Formato: Artigo
Idioma:Inglês
Publicado: Korean Society of Osteoporosis 2016
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6372746/
https://ncbi.nlm.nih.gov/pubmed/30775483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.afos.2016.07.002
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares